Comparative safety evaluation of non-narcotic analgesics

Journal of Clinical Epidemiology

Volumn 51, Issue 12, 1998, Pages 1357-1365

  Andrade, Susan E ^a   Martinez, Carlos ^b   Walker, Alexander M ^c  

^a UNIVERSITY OF RHODE ISLAND   (United States)

^b SANOFI   (France)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Acetaminophen; Aspirin; Diclofenac; Dipyrone; Mortality

Indexed keywords

ACETYLSALICYLIC ACID; ANALGESIC AGENT; DICLOFENAC; DIPYRONE; PARACETAMOL;

AGRANULOCYTOSIS; APLASTIC ANEMIA; ARTICLE; DRUG SAFETY; DRUG USE; GASTROINTESTINAL DISEASE; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; UNITED STATES;

ACETAMINOPHEN; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; DICLOFENAC; DIPYRONE; DRUG AND NARCOTIC CONTROL; DRUG EVALUATION; EPIDEMIOLOGIC METHODS; HUMANS; INCIDENCE; MIDDLE AGED; MORTALITY; RISK;

EID: 0032415821     PISSN: 08954356     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-4356(98)00076-6     Document Type: Article

References (56)

1. Arellano F., Sacristan J.A. Metamizole. Reassessment of its therapeutic role Eur J Clin Pharmacol. 38:1990;617-619.
2. Bollini P., Garcia Rodriguez L.A., Perez Gutthan S., Walker A.M. Bhe impact of research quality and study design on epidemiologic estimates of the effect of nonsteroidal anti-inflammatory drugs on upper gastrointestinal tract disease. Arch Intern Med. 152:1992;1289-1295.
3. Gabriel S.E., Jaakkimainen L., Bombardier C. Risk of serious gastrointestinal complications related to use of nonsteroidal anti-inflammatory drugs. A meta-analysis. Ann Intern Med. 115:1991;787-796.
4. Armstrong C.P., Blower A.L. Non-steroidal anti-inflammatory drugs and life threatening complications of peptic ulceration. Gut. 28:1987;527-532.
5. Needham C.D., Kyle J., Jones P.F., Johnston S.J., Kerridge D.F. Aspirin and alcohol in gastrointestinal haemorrhage. Gut. 12:1971;819-821.
6. Laporte J.R., Carne X., Vidal X., Moreno V., Juan J. Upper gastrointestinal bleeding in relation to previous use of analgesics and non-steroidal anti-inflammatory drugs. Lancet. 337:1991;85-89.
7. Faulkner G., Prichard P., Somerville K., Langman M.J.S. Aspirin and bleeding peptic ulcers in the elderly. Br Med J. 297:1988;1311-1313.
8. Langman M.J.S., Coggon D., Spiegelhalter D. Analgesic intake and the risk of acute upper gastrointestinal bleeding. Am J Med. 74:1983;79-82.
9. Langman M.J.S., Weil J., Wainwright P., Lawson D.H., Rawlins M.D., Logan R.F. Risks of bleeding peptic ulcer associated with individual non-steroidal anti-inflammatory drugs. Lancet. 343:1994;1075-1078.
10. Henry D., Dobson A., Turner C. Variability in the risk of major gastrointestinal complications from nonaspirin anti-inflammatory drugs. Gastroenter. 105:1993;1078-1088.
11. Alvarez A., Summerskill W.H.G. Gastrointestinal haemorrhage and salicylates. Lancet. 2:1958;920-925.
12. Levy M. Aspirin use in patients with major upper gastrointestinal bleeding and peptic ulcer disease. N Engl J Med. 290:1974;1158-1162.
13. Kaufman D.W., Kelly J.P., Levy M., Shapiro S. The Drug Etiology of Agranulocytosis and Aplastic Anemia. 1991;Oxford University Press, New York.
14. Miettinen O.S. Estimability and estimation in case-referent studies. Am J Epidem. 103(2):1976;226-235.
15. Van Der Klauw M.M., Stricker B.H.C., Herings R.M.C., Cost W.S., Valkenburg H.A., Wilson J.H. A population based case-cohort study of drug-induced anaphylaxis. Br J Clin Pharmac. 35:1993;400-408.
16. Johnston S.J., Jones P.F., Kyle J., Needham C.D. Epidemiology and course of gastrointestinal haemorrhage in north-east Scotland. Br Med J. 3:1973;655-660.
17. Somerville K., Faulkner G., Langman M. Non-steroidal anti-inflammatory drugs and bleeding peptic ulcer. Lancet. 1:1986;462-466.
18. Katschinski B.D., Logan R.F.A., Davies J., Langman M.J.S. Audit of mortality in upper gastrointestinal bleeding. Postgrad Med J. 65:1989;913-917.
19. Henry D., Robertson J. Nonsteroidal anti-inflammatory drugs and peptic ulcer hospitalization rates in New South Wales. Gastroenter. 104:1993;1083-1091.
20. Henry D.A., Johnston A., Dobson A., Duggan J. Fatal peptic ulcer complications and the use of non-steroidal anti-inflammatory drugs, aspirin, and corticosteroids. Br Med J. 295:1987;1227-1229.
21. Kaufman D.W., Kelly J.P., Ley M., Shapiro S. The drug etiology of agranulocytosis. An update of the International Agranulocytosis and Aplastic Anemia Study Pharmacoepi Drug Safety. 2:1993;S25-S29.
22. Roujeau J.C., Guillaume J.C., Fabre J.P., Penso D., Flechet M.L., Girre J.P. Toxic epidermal necrolysis (Lyell Syndrome). Incidence and drug etiology in France, 1981-1985. Arch Dermatol. 126:1990;37-42.
23. Steinberg W., Tenner S. Acute pancreatitis. N Engl J Med. 330(17):1994;1198-1210.
24. Thomson S.R., Hendry W.S., McFarlane G.A., Davidson A.I. Epidemiology and outcome of acute pancreatitis. Br J Surg. 74:1987;398-401.
25. Mann D.V., Hershman M.J., Hittinger R., Glazer G. Multicentre audit of death from acute pancreatitis. Br J Surg. 81:1994;890-893.
26. Carson J.L., Strom B.L., Duff A., Gupta A., Das K. Safety of nonsteroidal anti-inflammatory drugs with respect to acute liver disease. Arch Intern Med. 153:1993;1131-1336.
27. Garcia Rodriguez L.A., Perez Gutthan S., Walker A.M. The role of non-steroidal anti-inflammatory drugs in acute liver injury. Br Med J. 305:1992;865-868.
28. Garcia Rodriguez L.A., Williams R., Derby L.E., Dean A.D., Jick J. Acute liver injury associated with nonsteroidal anti-inflammatory drugs and the role of risk factors. Arch Intern Med. 154:1994;311-316.
29. Nuyts G.D., Elseviers M.M., De Broe M.E. Health impact of renal disease due to nephrotoxicity. Toxicol Letters. 46:1989;31-44.
30. Lauwerys R., Bernard A. Preclinical detection of nephrotoxicity. Description of the tests and appraisal of their health significance Toxicol Letters. 46:1989;13-29.
31. McMurray S.D., Luft F.C., Maxwell D.R., Hamburger R.J., Futty D., Szwed J.J. Prevailing patterns and predictor variables in patients with acute tubular necrosis. Arch Intern Med. 138:1978;950-955.
32. Chan H.L., Stern R.S., Arndt K.A., Langlois J., Jick S.S., Jick H. The incidence of erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis. Arch Dermatol. 126:1990;43-47.
33. Strom B.L., Carson J.L., Halpern A.C.et al. A population-based study of Stevens-Johnson syndrome. Arch Dermatol. 127:1991;831-838.
34. Schopf E., Stuhmer A., Rzany B., Victor N., Zentgraf R., Kapp J.F. Toxic epidermal necrolysis and Stevens-Johnson syndrome. Arch Dermatol. 127:1991;839-842.
35. Hurwitz E.S., Barret M.J., Bregman D., Gunn W.J.et al. Public Health Service study of Reye's syndrome and medications. JAMA. 257:1987;1905-1911.
36. Roujeau J.C., Keyy J.P., Naldi L.et al. Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis. N Engl J Med. 333:1995;1600-1607.
37. Dossing M., Sonne J. Drug-induced hepatic disorders. Incidence, management and avoidance Drug Safety. 9(6):1993;441-449.
38. Savage R.L., Moller P.W., Ballantyne C.L., Wells J.E. Variation in the risk of peptic ulcer complications with nonsteroidal antiinflammatory drug therapy. Arth Rheum. 36(1):1993;84-90.
39. Kaufman D.W., Kelly J.P., Sheehan J.E.et al. Nonsteroidal anti-inflammatory drug use in relation to major upper gastrointestinal bleeding. Clin Pharmacol Ther. 53:1993;485-494.
40. Garcia Rodriguez L.A., Walker A.M., Perez S. Nonsteroidal antiinflammatory drugs and gastrointestinal hospitalizations in Saskatchewan. A cohort study Epidemiology. 3:1992;337-342.
41. Nobili A., Mosconi P., Franzosi M.G., Tognoni G. Non-steroidal anti-inflammatory drugs and upper gastrointestinal bleeding, a post-marketing surveillance case-control study. Pharmacoepi Drug Safety. 1:1992;65-72.
42. Garcia Rodriguez L.A., Jick H. Risk of upper gastrointestinal bleeding and perforation associated with individual non-steroidal anti-inflammatory drugs. Lancet. 343:1994;769-772.
43. Begaud B., Chaslerie A., Carnet X.et al. Upper gastrointestinal bleeding associate with analgesics and NSAID use. A case-control study J Rheumat. 20:1993;1443-1444.
44. Holvoet J., Terriere L., Van Hee W.et al. Relation of upper gastrointestinal bleeding to non-steroidal anti-inflammatory drugs and aspirin. A case-control study Gut. 32(7):1991;730-734.
45. Lanza L.L., Walker A.M., Bortnichak E.A., Dreyer N.A. Peptic ulcer and gastrointestinal hemorrhage associated with nonsteroidal anti-inflammatory drug use in patients younger than 65 years. Arch Intern Med. 155:1995;1371-1377.
46. Pagini-Hill A., Chao A., Ross R.K., Henderson B.E. Aspirin use and chronic diseases. A cohort study of the elderly Br Med J. 299:1989;1247-1250.
47. Levy M., Miller D.R., Kaufman D.W.et al. Major upper gastrointestinal tract bleeding. Relation to the use of aspirin and other nonnarcotic analgesics Arch Intern Med. 148:1988;281-285.
48. Levy M. Aspirin use in patients with major upper gastrointestinal bleeding and peptic-ulcer disease. N Engl J Med. 290:1974;1158-1162.
49. Alexander A.M., Veitch G.B.A., Wood J.B. Anti-rheumatic and analgesic drug usage and acute gastro-intestinal bleeding in elderly patients. J Clin Hosp Pharm. 10:1985;89-93.
50. Bartle W.R., Gupta A.D., Lazor J. Nonsteroidal anti-inflammatory drugs and gastrointestinal bleeding. Arch Intern Med. 146:1986;2365-2367.
51. Weil J., Colin-Jones D., Langman M.et al. Prophylactic aspirin and risk of peptic ulcer bleeding. Br Med J. 310:1995;827-830.
52. Bochner B.S., Lichtenstein L.M. Anaphylaxis. N Engl J Med. 324(25):1991;1785-1790.
53. Beard P.H.G., Walker A.M., Perera D.R., Jick H. Nonsteroidal anti-inflammatory drugs and hospitalization for gastroesophageal bleeding in the elderly. Arch Intern Med. 147:1987;1621-1623.
54. Griffin M.R., Ray W.A., Schaffner W. Nonsteroidal anti-inflammatory drug use and death from peptic ulcer in elderly persons. Ann Intern Med. 109:1988;359-363.
55. Moride Y., Abenhaim L. Evidence of the depletion of susceptibles effect in non-experimental pharmacoepidemiologic research. J Clin Epidemiol. 47(7):1994;731-737.
56. Greenland S. Quantitative methods in the review of epidemiologic literature. Epidemiologic Reviews. 9:1987;1-30.